CBS 2019
CBSMD教育中心
English

推荐文献

科研文章

荐读文献

Major infections after bypass surgery and stenting for multivessel coronary disease in the randomised SYNTAX trial Treatment of higher-risk patients with an indication for revascularization: evolution within the field of contemporary percutaneous coronary intervention Novel functions of macrophages in the heart: insights into electrical conduction, stress, and diastolic dysfunction Dynamic atrioventricular delay programming improves ventricular electrical synchronization as evaluated by 3D vectorcardiography ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: A Report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography A Randomized Trial Comparing the NeoVas Sirolimus-Eluting Bioresorbable Scaffold and Metallic Everolimus-Eluting Stents Randomized Comparison of Ridaforolimus-Eluting and Zotarolimus-Eluting Coronary Stents 2-Year Clinical Outcomes: From the BIONICS and NIREUS Trials Individualizing Revascularization Strategy for Diabetic Patients With Multivessel Coronary Disease The spectrum of chronic coronary syndromes: genetics, imaging, and management after PCI and CABG Guiding Principles for Chronic Total Occlusion Percutaneous Coronary Intervention
|<<... 10 11 12 13 14 15 16 ...>>|

Recommandation StatementFeb 13, 2020

JOURNAL：ACC Article Link

ACC临床简报:新型冠状病毒对心脏的影响(2019-nCoV)

ACC Keywords: COVID-19

FULL TEXT PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top